Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation
Precision Genomics, a Ludwig Enterprises' subsidiary, has also developed the mRNA Inflammatory Index™ to monitors 48 mRNA biomarkers of chronic inflammation
SPARKS, NV / ACCESSWIRE / April 12, 2023 / Ludwig Enterprises, Inc, (OTC PINK:LUDG) (Ludwig - The Genomics Language Company) is proud to announce that its flagship nutraceutical, NuGenea™ launch will be forthcoming.
NuGenea, which means ‘New Life' in Greek, is a nutraceutical created by a physician and formulated with 20 different ingredients which have been scientifically shown to help fight chronic inflammation.
The World Health Organization (WHO) estimates that 50% to 60% of deaths worldwide result from illnesses that are caused by chronic inflammation including diabetes, COPD, heart disease and cancers.
"I personally researched the 20 ingredients that we included in NuGenea's formula," said Dr. Marvin S. Hausman MD, its creator. "I found 84 scientific studies that demonstrated how these compounds can impact mRNA biomarkers of chronic inflammation, also called cytokines and chemokines."
